Companies/US/NVCR

NOVOCURE LIMITED

Last · NASDAQ$13.84-0.46 (-3.22%)close · yahoo · 15h ago
Vol 1.19M ≈ 16.41M
Market cap$1.61B116.4M sh
P/E · TTM-10.6fwd -17.2 · eps -1.30 · loss
Beta0.99vs S&P 500
Div yield0.00%annual · TTM
52w range
$9.82$21.45
Volume1.2Msession

Issuer

Legal nameNOVOCURE LIMITED
HQUnited States (US)
ListingUS NVCR
ISINJE00BYSS4X48
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0001645113
CIK0001645113
LinkedIn
Employees1,605
AddressNovoCure Ltd. No. 4 The Forum JE2 4UF, St. Helier
Headline financial metrics
Revenue$357.6M
Operating income$-78.0M
Net income$-86.8M
Free cash flow$-17.5M
Operating margin-21.8%
Net margin-24.3%
Return on equity-25.7%
Period2026
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.23
Est. revenue
182.2M

Documents

FormReporting forFiledFlags
2026-06-302026-07-23 5